Periodical (Journal)

ISSN  :   2515-5091 ( Online )   Open Access   Active

Aim & Scope
JNCI Cancer Spectrum is an international, peer-reviewed, open access journal, publishing across the spectrum of oncology research. The journal welcomes articles in basic, translational, and clinical research, prevention, screening, treatment, epidemiology, public health, and policy. In addition to novel results, the journal will also consider studies with meaningful confirmatory or negative findings, and it will encourage systematic reviews, meta-analyses and expert reviews of important topics. The journal will also consider scholarly manuscripts discussing emerging hypotheses and research priorities. [1]

Go to Website

2020 - VOLUME 4, ISSUE 3
11 RESULTS in 205 msec
Insomnia and Neurocognitive Functioning in Adult Survivors of Childhood Cancer.

I Tonning Olsson , MM Lubas , C Li , ... , TM Brinkman

JNCI Cancer Spectrum, 2020 - VOLUME 4, ISSUE 3, p pkaa008.

  Journal Article
0 55
Urinary Estrogen Metabolites and Long-Term Mortality Following Breast Cancer.

T Wang , HB Nichols , SJ Nyante , ... , MD Gammon

JNCI Cancer Spectrum, 2020 - VOLUME 4, ISSUE 3, p pkaa014.

  Journal Article
0 44
Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24‚ÄČ900 Survivors.

MT Milano , PC Dinh , H Yang , ... , C Fung

JNCI Cancer Spectrum, 2020 - VOLUME 4, ISSUE 3, p pkaa017.

  Journal Article
0 45
Genetic Counseling and Germline Testing in the Era of Tumor Sequencing: A Cohort Study.

S Klek , B Heald , A Milinovich , ... , P Funchain

JNCI Cancer Spectrum, 2020 - VOLUME 4, ISSUE 3, p pkaa018.

  Journal Article
0 8
A Clinical Approach to Detecting Germline Pathogenic Variants From Tumor-Only Sequencing.

O Ceyhan-Birsoy PhD , M Misyura , D Mandelker

JNCI Cancer Spectrum, 2020 - VOLUME 4, ISSUE 3, p pkaa019.

  Editorial
0 16
Evaluating the Utility of Polygenic Risk Scores in Identifying High-Risk Individuals for Eight Common Cancers.

G Jia , Y Lu , W Wen , ... , W Zheng

JNCI Cancer Spectrum, 2020 - VOLUME 4, ISSUE 3, p pkaa021.

  Journal Article
0 28
Contribution of Immunoscore and Molecular Features to Survival Prediction in Stage III Colon Cancer.

FA Sinicrope , Q Shi , F Hermitte , ... , SR Alberts

JNCI Cancer Spectrum, 2020 - VOLUME 4, ISSUE 3, p pkaa023.

  Journal Article
0 28
Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7).

O Colomban , M Tod , J Peron , ... , B You

JNCI Cancer Spectrum, 2020 - VOLUME 4, ISSUE 3, p pkaa026.

  Journal Article
0 10